OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An overview of rational design of mRNA-based therapeutics and vaccines
Kenneth K.W. To, William C. Cho
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 11, pp. 1307-1317
Closed Access | Times Cited: 72
Kenneth K.W. To, William C. Cho
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 11, pp. 1307-1317
Closed Access | Times Cited: 72
Showing 26-50 of 72 citing articles:
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
mRNA therapy: A new frontier in regenerative medicine
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
Akmal Zubair, Hanbal Ahmad, Muhammad Arif, et al.
HIV Medicine (2025)
Closed Access
Advances in mucosal vaccines: Design strategies for antigens, adjuvants, and delivery systems
Jiaxin Guo, Yongyi Xie, Muhammad Waqqas Hasan, et al.
Chinese Chemical Letters (2025), pp. 111213-111213
Closed Access
Jiaxin Guo, Yongyi Xie, Muhammad Waqqas Hasan, et al.
Chinese Chemical Letters (2025), pp. 111213-111213
Closed Access
Enzymatic isolation and microfluidic electrophoresis analysis of residual dsRNA impurities in mRNA vaccines and therapeutics
Adriana Coll De Peña, Matei Vaduva, Nina Li, et al.
The Analyst (2024) Vol. 149, Iss. 5, pp. 1509-1517
Open Access | Times Cited: 3
Adriana Coll De Peña, Matei Vaduva, Nina Li, et al.
The Analyst (2024) Vol. 149, Iss. 5, pp. 1509-1517
Open Access | Times Cited: 3
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 3
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 3
Smart nucleic acid nanodrug delivery system for precision therapeutics
Yu Chen, Zongkang Guo, Jing Li, et al.
Coordination Chemistry Reviews (2025) Vol. 535, pp. 216673-216673
Closed Access
Yu Chen, Zongkang Guo, Jing Li, et al.
Coordination Chemistry Reviews (2025) Vol. 535, pp. 216673-216673
Closed Access
Advances in mRNA and other vaccines against MERS-CoV
Wanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Translational research (2021) Vol. 242, pp. 20-37
Open Access | Times Cited: 23
Wanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Translational research (2021) Vol. 242, pp. 20-37
Open Access | Times Cited: 23
Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases
Seokhwan Chung, Chan Mi Lee, Miqin Zhang
Nanoscale Horizons (2022) Vol. 8, Iss. 1, pp. 10-28
Open Access | Times Cited: 16
Seokhwan Chung, Chan Mi Lee, Miqin Zhang
Nanoscale Horizons (2022) Vol. 8, Iss. 1, pp. 10-28
Open Access | Times Cited: 16
Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
Xiao Guo, Dongying Liu, Yukai Huang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Xiao Guo, Dongying Liu, Yukai Huang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Wubetu Yihunie, Getinet Nibret, Yibeltal Aschale
Clinical Pharmacology Advances and Applications (2023) Vol. Volume 15, pp. 77-98
Open Access | Times Cited: 7
Wubetu Yihunie, Getinet Nibret, Yibeltal Aschale
Clinical Pharmacology Advances and Applications (2023) Vol. Volume 15, pp. 77-98
Open Access | Times Cited: 7
Immunoinformatic of novel self-amplifying mRNA vaccine lipid nanoparticle against SARS-CoV-2
Turmidzi Fath, Endang Winiati Bachtiar, Gulimiran Alitongbieke, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2024) Vol. 15, Iss. 2, pp. 91-98
Open Access | Times Cited: 2
Turmidzi Fath, Endang Winiati Bachtiar, Gulimiran Alitongbieke, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2024) Vol. 15, Iss. 2, pp. 91-98
Open Access | Times Cited: 2
Comprehensive translational profiling and STE AI uncover rapid control of protein biosynthesis during cell stress
Attila Horváth, Yoshika Janapala, Katrina Woodward, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7925-7946
Open Access | Times Cited: 2
Attila Horváth, Yoshika Janapala, Katrina Woodward, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7925-7946
Open Access | Times Cited: 2
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Message in a bottle: mRNA vaccination for influenza
Jessica R. Shartouny, Anice C. Lowen
Journal of General Virology (2022) Vol. 103, Iss. 7
Open Access | Times Cited: 9
Jessica R. Shartouny, Anice C. Lowen
Journal of General Virology (2022) Vol. 103, Iss. 7
Open Access | Times Cited: 9
Liquid Chromatography–Mass Spectrometry-Based Qualitative Profiling of mRNA Therapeutic Reagents Using Stable Isotope-Labeled Standards Followed by the Automatic Quantitation Software Ariadne
Hiroshi Nakayama, Yuko Nobe, Masami Koike, et al.
Analytical Chemistry (2022)
Open Access | Times Cited: 9
Hiroshi Nakayama, Yuko Nobe, Masami Koike, et al.
Analytical Chemistry (2022)
Open Access | Times Cited: 9
Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity
Lin Wang, Huanchun Xing, Shuai Guo, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Lin Wang, Huanchun Xing, Shuai Guo, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 5
mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
Peixian Chen, Xiaoye Shi, Weixin He, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Peixian Chen, Xiaoye Shi, Weixin He, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat
S. McCarthy, Christopher B. Rohde, Matt Angel, et al.
Nucleic Acid Therapeutics (2023) Vol. 33, Iss. 2, pp. 148-158
Open Access | Times Cited: 4
S. McCarthy, Christopher B. Rohde, Matt Angel, et al.
Nucleic Acid Therapeutics (2023) Vol. 33, Iss. 2, pp. 148-158
Open Access | Times Cited: 4
Biosafety and regulatory issues of RNA therapeutics
Huệ Vũ Thị, Lan-Anh Nguyen Thi, Thuy Linh Tang, et al.
Progress in molecular biology and translational science (2024), pp. 311-329
Closed Access | Times Cited: 1
Huệ Vũ Thị, Lan-Anh Nguyen Thi, Thuy Linh Tang, et al.
Progress in molecular biology and translational science (2024), pp. 311-329
Closed Access | Times Cited: 1
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
Elisabetta Poluzzi, Emanuel Raschi, Carlotta Lunghi, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1
Elisabetta Poluzzi, Emanuel Raschi, Carlotta Lunghi, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1
Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA
Eleanor Woodward, Edina Wang, Christopher J.D. Wallis, et al.
Methods in molecular biology (2024), pp. 267-287
Closed Access | Times Cited: 1
Eleanor Woodward, Edina Wang, Christopher J.D. Wallis, et al.
Methods in molecular biology (2024), pp. 267-287
Closed Access | Times Cited: 1
mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 1
Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 1
Experimental considerations for precise RNA-mediated insertion of transgenes
Sarah M. Palm, Briana Van Treeck, Kathleen Collins
Methods in enzymology on CD-ROM/Methods in enzymology (2024), pp. 1-24
Closed Access | Times Cited: 1
Sarah M. Palm, Briana Van Treeck, Kathleen Collins
Methods in enzymology on CD-ROM/Methods in enzymology (2024), pp. 1-24
Closed Access | Times Cited: 1
mRNA vaccines as cancer therapies
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
